
Please try another search
By Dietrich Knauth
(Reuters) -West Virginia's cities and counties reached a $400 million settlement on Monday with drug distributors McKesson Corp (NYSE:MCK), AmerisourceBergen (NYSE:ABC) Corp and Cardinal Health Inc (NYSE:CAH), resolving the local governments' allegations that the three companies fueled an opioid crisis in the state.
More than 100 local governments had sued the drug distributors, alleging they recklessly oversupplied West Virginia with prescription pain medication. The settlement ends those lawsuits and builds on the companies' previous settlements with the state Attorney General's office.
"I'm happy to see the judicial system work as it should by benefiting West Virginia communities that have been hit hard by opioid abuse," West Virginia Attorney General Patrick Morrisey said in a statement.
Cardinal Health said in a statement that the settlement will provide funds to West Virginia communities in need, and that it remains committed to being "a part of the solution to the opioid epidemic."
McKesson, Cardinal Health and AmerisourceBergen, along with Johnson & Johnson (NYSE:JNJ), previously agreed to a $26 billion nationwide settlement of opioid litigation, but that settlement did not include West Virginia.
West Virginia previously settled the state's claims against the three companies, but its local governments brought their own lawsuits separately from the state litigation.
The $400 million city and county settlement does not include two local governments, the City of Huntington and Cabell County, which sued the three companies in federal court. Huntington and Cabell County lost their federal court case on July 4.
"The exclusion of Huntington and Cabell County is particularly painful because this community is the epicenter of the opioid epidemic," said Paul Farrell, an attorney representing the West Virginia cities and counties.
More than 3,300 lawsuits in the United States have been filed by local and tribal governments over the opioid abuse and overdose epidemic. They accuse drugmakers of downplaying the risks of the addictive pain medicines and distributors and pharmacies of ignoring red flags that the drugs were being diverted into illegal channels.
U.S. officials have said that by 2019, the health crisis led to nearly 500,000 opioid overdose deaths over two decades.
(Reuters) - Russia has failed to gain ground in cyberspace against Ukraine almost six months after its invasion of the country, the head of Britain's GCHQ intelligence service...
By David Shepardson WASHINGTON (Reuters) -General Motors Co and LG Energy Solution are considering a site in Indiana for a fourth U.S. battery cell manufacturing plant, a...
By Mrinalika Roy (Reuters) -Bluebird bio slumped nearly 15% on Thursday as investors fretted over sales potential of its newly approved ultra-rare blood disorder gene therapy that...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.